# Intas Pharmaceuticals Limited – FDA Inspection, May 12, 2023

Source: https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/cc06d269-7eb7-476e-8b4c-d7dbea9b39ff
Source feed: FDA_Inspections

> FDA inspection 1206170 of Intas Pharmaceuticals Limited, May 12, 2023. 16 citations under 21 CFR part 211. Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206170
- Company Name: Intas Pharmaceuticals Limited
- Inspection Date: 2023-05-12
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 16

## Related Documents

- FDA Inspection 1245599 - 2024-07-12
- [FDA Inspection 1098380 - 2019-08-02](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/0895eb6a-065a-49a6-ac84-da712eda4358)
- [FDA Inspection 1074349 - 2018-12-14](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/fbcaf201-b95a-47b1-9d62-b65a4c37d203)
- FDA Inspection 1067525 - 2018-08-17
- [FDA Inspection 1056170 - 2018-06-08](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/40778dca-3416-4505-9b4f-98131521219b)

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Investigator](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- Issuing Officer

Company: https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
